Relation between C reactive protein concentrations and coronary microvascular endothelial function

被引:82
作者
Teragawa, H
Fukuda, Y
Matsuda, K
Ueda, K
Higashi, Y
Oshima, T
Yoshizumi, M
Chayama, K
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cardiovasc Physiol & Med, Hiroshima 7348551, Japan
[3] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Lab Med, Hiroshima 7348551, Japan
关键词
D O I
10.1136/hrt.2003.022269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine how C reactive protein (CRP), a sensitive marker of inflammation, is related to coronary endothelial function. Design: Changes in quantitative coronary angiographic findings and Doppler flow velocity measurements in response to locally infused acetylcholine were assessed. Setting: Tertiary cardiology centre. Patients: 46 patients with angiographically normal coronary arteries were divided into groups with normal (less than or equal to3 mg/l) or increased (>3 mg/l) CRP concentrations. Interventions: Acetylcholine (3 and 30 mug/min) was infused into the left coronary ostium for two minutes. Main outcome measures: Percentage change in diameter of epicardial coronary arteries and coronary blood flow (CBF) in response to acetylcholine; and correlations between these parameters and serum CRP concentrations. Results: 15 patients had increased CRP concentrations. The change in coronary artery diameter induced by acetylcholine infusion was similar between the groups but the increase in CBF induced by acetylcholine was smaller in patients with increased CRP concentrations (54.9% v 139.4% with acetylcholine 30 mug/min, p = 0.0030). Multivariate analysis identified increased CRP concentration as independently associated with attenuated CBF response to acetylcholine at 30 mug/min ( p = 0.0078, R-2 = 0.434). Conclusions: These findings suggest that inflammation appears to be associated with impaired coronary endothelial function in resistance but not conduit vessels. The data suggest a close relation between chronic vascular inflammation and endothelial dysfunction in atherosclerosis.
引用
收藏
页码:750 / 754
页数:5
相关论文
共 33 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   The major receptor for C-reactive protein on leukocytes is Fcγ receptor II [J].
Bharadwaj, D ;
Stein, MP ;
Volzer, M ;
Mold, C ;
Du Clos, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :585-590
[3]   Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia [J].
Capell, WH ;
DeSouza, CA ;
Poirier, P ;
Bell, ML ;
Stauffer, BL ;
Weil, KM ;
Hernandez, TL ;
Eckel, RH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :307-313
[4]   C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites [J].
Chambers, JC ;
Eda, S ;
Bassett, P ;
Karim, Y ;
Thompson, SG ;
Gallimore, JR ;
Pepys, MB ;
Kooner, JS .
CIRCULATION, 2001, 104 (02) :145-150
[5]   Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease [J].
Cleland, SJ ;
Sattar, N ;
Petrie, JR ;
Forouhi, NG ;
Elliott, HL ;
Connell, JMC .
CLINICAL SCIENCE, 2000, 98 (05) :531-535
[6]   Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations:: A placebo-controlled study using a highly sensitive C-reactive protein assay [J].
Feldman, M ;
Jialal, I ;
Devaraj, S ;
Cryer, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (08) :2036-2041
[7]   Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].
Fichtlscherer, S ;
Rosenberger, G ;
Walter, DH ;
Breuer, S ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2000, 102 (09) :1000-1006
[8]   Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia [J].
Fukuda, Y ;
Teragawa, H ;
Matsuda, K ;
Yamagata, T ;
Matsuura, H ;
Chayama, K .
HEART, 2002, 87 (03) :264-269
[9]   Acute systemic inflammation impairs endothelium-dependent dilatation in humans [J].
Hingorani, AD ;
Cross, J ;
Kharbanda, RK ;
Mullen, MJ ;
Bhagat, K ;
Taylor, M ;
Donald, AE ;
Palacios, M ;
Griffin, GE ;
Deanfield, JE ;
MacAllister, RJ ;
Vallance, P .
CIRCULATION, 2000, 102 (09) :994-999
[10]   Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease [J].
Horne, BD ;
Muhlestein, JB ;
Carlquist, JF ;
Bair, TL ;
Madsen, TE ;
Hart, NI ;
Anderson, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1774-1780